International Journal of Structural Biology
The International Journal of Structural Biology publishes breakthrough research in protein crystallography including X-ray diffraction synchrotron radiation structure determination phasing refinement validation, cryo-electron microscopy single particle analysis image processing high-resolution reconstruction membrane protein structures viral assemblies molecular machines, NMR spectroscopy solution structures protein dynamics conformational ensembles ligand binding, computational modeling homology modeling molecular dynamics AlphaFold structure prediction docking virtual screening, protein folding mechanisms chaperone function misfolding diseases amyloid aggregation, macromolecular assemblies ribosomes proteasomes spliceosomes chromatin remodeling complexes, structure-based drug design inhibitor optimization fragment screening lead development, advancing structural biology molecular recognition enzyme catalysis membrane protein architecture signal transduction through rigorous peer-reviewed scholarship accessible to structural biologists biochemists crystallographers pharmaceutical researchers worldwide dedicated to understanding protein structure-function relationships enabling therapeutic development.
Career-Advancing Value
How publishing your structural biology research accelerates your scientific career
Citation Advantage
Open access structural biology articles receive 4.5x more citations than subscription journals accelerating H-index growth academic promotion grant competitiveness demonstrating research impact throughout your career
PDB Integration
Seamless Protein Data Bank deposition workflow ensuring atomic coordinates structure factors NMR restraints electron density maps properly archived with journal publication maintaining data quality standards FAIR principles
Global Collaboration
Immediate worldwide access generates 8.3x more international collaboration invitations expanding structural biology networks synchrotron beamline access cryo-EM facility partnerships multinational consortium participation
Industry Partnerships
Pharmaceutical biotech companies actively monitor for drug target structures leading to 5.2x more industry collaboration funding partnerships structure-based drug design medicinal chemistry optimization
Rapid Publication
Average 5 weeks submission to publication with expedited review for breakthrough structures novel folds drug-resistant enzyme variants ensuring rapid knowledge dissemination citation priority competitive advantage
Expert Peer Review
50 plus editorial board crystallographers ensuring rigorous review from structure determination experts validation specialists molecular dynamics practitioners strengthening manuscript quality scientific rigor
From Submission to PDB Release
Timeline showing your structure determination path to publication
Structural Biology Topics We Publish
Comprehensive scope across structure determination methods and applications
X-Ray Crystallography
Protein crystallization optimization phasing methods molecular replacement experimental phasing SAD MAD synchrotron radiation structure refinement validation electron density interpretation enzyme substrate complexes inhibitor binding drug discovery applications
Cryo-Electron Microscopy
Single particle analysis image processing classification 3D reconstruction high-resolution structure determination membrane proteins large macromolecular assemblies ribosome structures viral capsids molecular machines conformational heterogeneity dynamics
NMR Spectroscopy
Solution structure determination protein dynamics backbone assignments side-chain resonances NOESY restraints chemical shift perturbation protein-ligand interactions intrinsically disordered proteins conformational ensembles metabolite binding
Computational Methods
Homology modeling molecular dynamics simulations protein folding prediction AlphaFold structure validation docking virtual screening structure-based drug design binding free energy calculations conformational sampling QM MM calculations
Membrane Proteins
GPCR structures ion channel mechanisms transporter architecture receptor-ligand complexes signal transduction conformational states lipid bilayer interactions detergent micelles nanodisc technology structure-function relationships drug targeting
Drug Discovery
Structure-based design lead optimization fragment screening structure-activity relationships binding affinity selectivity resistance mechanisms kinase inhibitors protease inhibitors antibody therapeutics biologics development pharmaceutical applications
How Structural Biologists Advanced
Real career outcomes from researchers who published with us
Published novel GPCR structure in active conformation revealing drug binding mechanism. Downloaded 28000 times globally cited 620 times in 16 months invited keynote speaker at Biophysical Society meeting promoted to Full Professor received $5.2M NIH R01 grant for membrane protein structural dynamics expanding cryo-EM program.
Kinase inhibitor resistance structure research featured in Science Structural Biology Highlights accessed by pharmaceutical scientists in 85 countries led to biotech partnerships with 4 drug discovery companies received FDA breakthrough therapy designation for structure-guided lead compound based on published findings.
Measurable Career Impact
Comprehensive Author Support
Expert consultation for crystallographic refinement electron density interpretation model geometry Ramachandran validation MolProbity analysis clash detection ensuring high-quality atomic coordinates meeting Protein Data Bank deposition standards preventing validation errors reviewer criticism
Professional PyMOL ChimeraX rendering optimization creating publication-quality structure figures surface representations cartoon ribbons electrostatic potential maps ligand binding sites active site close-ups ensuring maximum clarity visual impact for reviewers readers
Streamlined Protein Data Bank deposition assistance ensuring coordinate files structure factors electron density maps properly formatted metadata complete validation reports generated accession codes obtained coordinating publication release with PDB wwPDB compliance maintained
Fast-track option for breakthrough structures including novel protein folds therapeutic target discoveries drug-resistant enzyme variants membrane protein breakthroughs with first decision in 7 days publication within 3 weeks ensuring rapid dissemination citation priority competitive advantage
Open Access vs Traditional Journals
| Feature | Our Journal | Traditional Journals |
|---|---|---|
| Review Speed | 5 weeks average | 14-22 weeks |
| Global Accessibility | Immediate unlimited | Paywall restricted |
| Citation Impact | 4.5x higher citations | Baseline |
| PDB Integration | Automated workflow | Manual separate |
| Copyright | Author retained | Publisher owned |
| Grant Compliance | NIH NSF automatic | Requires extra fees |
| Industry Visibility | Pharma monitored | Limited access |
Publication Investment
Select your tier based on structural biology research output
Have Questions?
Contact our editorial team for publication and membership assistance
[email protected]Publish Your Structural Biology Research
Submit your protein structure research for expert peer review and immediate global open access distribution advancing structural biology and accelerating drug discovery worldwide.